Great Basin Scientific (GBSN) : During the past 4 weeks, traders have been relatively bearish on Great Basin Scientific (GBSN), hence the stock is down -56.36% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -31.51% relative to the S&P 500. The 4-week change in the price of the stock is -53.41% and the stock has fallen -31.09% in the past 1 week.
Great Basin Scientific (NASDAQ:GBSN): The stock opened at $0.84 on Friday but the bulls could not build on the opening and the stock topped out at $0.94 for the day. The stock traded down to $0.81 during the day, due to lack of any buying support eventually closed down at $0.82 with a loss of -8.85% for the day. The stock had closed at $0.90 on the previous day. The total traded volume was 976,797 shares.
The stock has recorded a 20-day Moving Average of 42.91% and the 50-Day Moving Average is 54.24%. Great Basin Scientific, Inc. has dropped 75.74% during the last 3-month period . Year-to-Date the stock performance stands at -97.51%.
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially available test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA). The Companys products under development also include a diagnostic test for Group B Strep., Staphylococcus Identification and Resistance Blood Infection Panel (Staph ID/R panel), STEC Test, Staph aureus (SA) Pre-Surgical Nasal Screen Test, Food Borne Pathogens Panel and Candida Blood Infection Panel. The Companys platform is an automated molecular diagnostic system, consisting of an analyzer and associated diagnostic tests.